www.fgks.org   »   [go: up one dir, main page]
Skip navigation

Chemical Hydroxyprogesterones

1–50 of 123 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 11-hydroxyprogesterone regulation of metabolic process Soot [Soot affects regulation of metabolic process] which results in decreased abundance of 11-hydroxyprogesterone 1: Rattus norvegicus Serum   1
2. 11-hydroxyprogesterone 11-glucuronide regulation of cellular metabolic process deoxynivalenol [deoxynivalenol affects regulation of cellular metabolic process] which results in decreased abundance of 11-hydroxyprogesterone 11-glucuronide 1: Sus scrofa Intestinal Mucosa | Cell Line   1
3. 17,20-dihydroxy-4-pregnen-3-one androgen receptor signaling pathway 17,20-dihydroxy-4-pregnen-3-one results in increased androgen receptor signaling pathway 1: Gnathopogon caerulescens Sertoli Cells   1
4. 17,20-dihydroxy-4-pregnen-3-one steroid biosynthetic process bisphenol A [bisphenol A affects steroid biosynthetic process] which results in increased abundance of 17,20-dihydroxy-4-pregnen-3-one 1: Sparus aurata Plasma   1
5. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line 1 gene view node 1
6. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene view node 1
7. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which affects the abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene view node 1
8. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which results in increased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line 1 gene view node 1
9. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Colforsin [Colforsin results in increased steroid biosynthetic process] which results in increased secretion of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor
3 genes view node 		1
10. 17-alpha-Hydroxyprogesterone negative regulation of steroid hormone biosynthetic process Venlafaxine Hydrochloride [Venlafaxine Hydrochloride results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
11. 17-alpha-Hydroxyprogesterone negative regulation of steroid hormone biosynthetic process Tramadol [Tramadol results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
12. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor
3 genes view node 		1
13. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Testis
3 genes view node 		1
14. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Adrenal Glands
3 genes view node 		1
15. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Plasma
3 genes view node 		1
16. 17-alpha-Hydroxyprogesterone positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | Dexamethasone | INS | Rosiglitazone 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage] 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
17. 17-alpha-Hydroxyprogesterone positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
18. 17-alpha-Hydroxyprogesterone negative regulation of fat cell differentiation 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased negative regulation of fat cell differentiation 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured
2 genes view node 		1
19. 17-alpha-Hydroxyprogesterone progesterone metabolic process perfluorooctanoic acid [perfluorooctanoic acid affects progesterone metabolic process] which affects the secretion of 17-alpha-Hydroxyprogesterone 1: Mus musculus Leydig Cells | Cell Line, Tumor
2 genes view node 		1
20. 17-alpha-Hydroxyprogesterone positive regulation of steroid biosynthetic process 8-Bromo Cyclic Adenosine Monophosphate [8-Bromo Cyclic Adenosine Monophosphate results in increased positive regulation of steroid biosynthetic process] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone 1: Mus musculus Leydig Cells | Cell Line   1
21. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity Clotrimazole | CYP17A1 [[Clotrimazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone Cell-Free System   1
22. 17-alpha-Hydroxyprogesterone negative regulation of lyase activity Clotrimazole | CYP17A1 [[Clotrimazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of lyase activity] which results in increased metabolism of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
23. 17-alpha-Hydroxyprogesterone negative regulation of steroid hormone biosynthetic process Clotrimazole [Clotrimazole results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
24. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity CYP17A1 | Miconazole [[Miconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
25. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity CYP17A1 | Miconazole [[Miconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone Cell-Free System   1
26. 17-alpha-Hydroxyprogesterone negative regulation of lyase activity CYP17A1 | Miconazole [[Miconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of lyase activity] which results in decreased metabolism of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
27. 17-alpha-Hydroxyprogesterone regulation of steroid hormone biosynthetic process Miconazole [Miconazole affects regulation of steroid hormone biosynthetic process] which results in increased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
28. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity CYP17A1 | Ketoconazole [[Ketoconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
29. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity CYP17A1 | Ketoconazole [[Ketoconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone Cell-Free System   1
30. 17-alpha-Hydroxyprogesterone negative regulation of lyase activity CYP17A1 | Ketoconazole [[Ketoconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of lyase activity] which results in decreased metabolism of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
31. 17-alpha-Hydroxyprogesterone regulation of steroid hormone biosynthetic process Ketoconazole [Ketoconazole affects regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
32. 17-alpha-Hydroxyprogesterone positive regulation of oxidoreductase activity CYP17A1 | Fluconazole [[Fluconazole affects the activity of CYP17A1 protein] which results in increased positive regulation of oxidoreductase activity] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
33. 17-alpha-Hydroxyprogesterone negative regulation of lyase activity CYP17A1 | Fluconazole [[Fluconazole affects the activity of CYP17A1 protein] which results in increased negative regulation of lyase activity] which results in decreased metabolism of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
34. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity CYP17A1 | Fluconazole [[Fluconazole results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone Cell-Free System   1
35. 17-alpha-Hydroxyprogesterone regulation of steroid hormone biosynthetic process Fluconazole [Fluconazole affects regulation of steroid hormone biosynthetic process] which results in increased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
36. 17-alpha-Hydroxyprogesterone negative regulation of oxidoreductase activity abiraterone | CYP17A1 [[abiraterone results in decreased activity of CYP17A1 protein] which results in increased negative regulation of oxidoreductase activity] which results in decreased chemical synthesis of 17-alpha-Hydroxyprogesterone Cell-Free System   1
37. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Ketoconazole [Ketoconazole affects steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Macaca fascicularis Blood
3 genes view node 		1
38. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Metyrapone [Metyrapone affects steroid biosynthetic process] which results in increased abundance of 17-alpha-Hydroxyprogesterone 1: Macaca fascicularis Blood
3 genes view node 		1
39. 17 alpha-Hydroxyprogesterone Caproate positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | Dexamethasone | INS | Rosiglitazone 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage] 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
40. 17 alpha-Hydroxyprogesterone Caproate positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17 alpha-Hydroxyprogesterone Caproate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
41. 17 alpha-Hydroxyprogesterone Caproate negative regulation of fat cell differentiation 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17 alpha-Hydroxyprogesterone Caproate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased negative regulation of fat cell differentiation 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured
3 genes view node 		1
42. 7-hydroxyprogesterone progesterone secretion Sodium Glutamate [Sodium Glutamate results in decreased progesterone secretion] which results in decreased abundance of 7-hydroxyprogesterone 1: Rattus norvegicus Leydig Cells   1
43. Medroxyprogesterone spermatogenesis Testosterone [Medroxyprogesterone co-treated with Testosterone] results in decreased spermatogenesis 1: Homo sapiens Testis
2 genes view node 		1
44. Medroxyprogesterone metabolic process 2-chloroethyl ethyl sulfide [2-chloroethyl ethyl sulfide affects metabolic process] which results in increased abundance of Medroxyprogesterone 1: Mus musculus Plasma   1
45. Medroxyprogesterone Acetate MAPK cascade Medroxyprogesterone Acetate results in increased MAPK cascade 1: Mus musculus Mammary Glands, Animal | Tumor Cells, Cultured
9 genes view node 		1
46. Medroxyprogesterone Acetate cell population proliferation Mifepristone Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased cell population proliferation] 1: Mus musculus Mammary Glands, Animal | Tumor Cells, Cultured
19 genes view node 		1
47. Medroxyprogesterone Acetate cell population proliferation Medroxyprogesterone Acetate results in increased cell population proliferation 1: Mus musculus Mammary Glands, Animal | Tumor Cells, Cultured
19 genes view node 		1
48. Medroxyprogesterone Acetate apoptotic process Bezafibrate [Bezafibrate co-treated with Medroxyprogesterone Acetate] results in increased apoptotic process 1: Homo sapiens Lymphocytes | Tumor Cells, Cultured
35 genes view node 		1
49. Medroxyprogesterone Acetate apoptotic process Bezafibrate | CD40LG CD40LG protein inhibits the reaction [[Bezafibrate co-treated with Medroxyprogesterone Acetate] results in increased apoptotic process] 1: Homo sapiens Lymphocytes | Tumor Cells, Cultured
35 genes view node 		1
50. Medroxyprogesterone Acetate apoptotic process Bezafibrate | CD40LG | lycorine lycorine inhibits the reaction [CD40LG protein inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Bezafibrate] results in increased apoptotic process]] 1: Homo sapiens Lymphocytes | Tumor Cells, Cultured
35 genes view node 		1
1–50 of 123 results.
Download: CSV| Excel| XML| TSV